Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207,440,936
-
Total 13F shares
-
3,501,400
-
Share change
-
-300
-
Total reported value
-
$85,642,436
-
Price per share
-
$24.46
-
Number of holders
-
49
-
Value change
-
+$3,067,413
-
Number of buys
-
26
-
Number of sells
-
19
Institutional Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q3 2014
As of 30 Sep 2014,
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,501,400 shares.
The largest 10 holders included
Pentwater Capital Management LP, WASATCH ADVISORS INC, BlackRock Fund Advisors, VANGUARD GROUP INC, MORGAN STANLEY, Iguana Healthcare Management, LLC, DEUTSCHE BANK AG\, EverPoint Asset Management, LLC, FMR LLC, and Rhenman & Partners Asset Management AB.
This page lists
49
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.